Dinglan Wu, Ph.D.
Affiliations: | 2012 | The Chinese University of Hong Kong, Hong Kong, Hong Kong |
Area:
Oncology, Molecular Biology, Pathology, Cell BiologyGoogle:
"Dinglan Wu"Parents
Sign in to add mentor| Yu Pang Eric Cho | grad student | 2012 | Chinese University of Hong Kong | |
| (A Functional Study of an Orphan Nuclear Receptor TLX in Prostate Cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Liu P, Wang W, Wang F, et al. (2023) Alterations of plasma exosomal proteins and motabolies are associated with the progression of castration-resistant prostate cancer. Journal of Translational Medicine. 21: 40 |
| Wang W, Wu Q, Mohyeddin A, et al. (2022) Identification of the Key Genes Involved in the Tumorigenesis and Prognosis of Prostate Cancer. Computational and Mathematical Methods in Medicine. 2022: 5500416 |
| Wang Y, Fan J, Chen T, et al. (2022) A novel ferroptosis-related gene prognostic index for prognosis and response to immunotherapy in patients with prostate cancer. Frontiers in Endocrinology. 13: 975623 |
| Gao W, Wang Y, Yu S, et al. (2022) Endothelial nitric oxide synthase (eNOS)-NO signaling axis functions to promote the growth of prostate cancer stem-like cells. Stem Cell Research & Therapy. 13: 188 |
| Yu YZ, Lv DJ, Wang C, et al. (2022) Hsa_circ_0003258 promotes prostate cancer metastasis by complexing with IGF2BP3 and sponging miR-653-5p. Molecular Cancer. 21: 12 |
| Zhou J, Wang Y, Wu D, et al. (2021) Orphan nuclear receptors as regulators of intratumoral androgen biosynthesis in castration-resistant prostate cancer. Oncogene |
| Wang Z, Li Y, Wang Y, et al. (2020) Targeting prostate cancer stem-like cells by an immunotherapeutic platform based on immunogenic peptide-sensitized dendritic cells-cytokine-induced killer cells. Stem Cell Research & Therapy. 11: 123 |
| Wang Z, Li Y, Wu D, et al. (2019) Nuclear receptor HNF4α performs a tumor suppressor function in prostate cancer via its induction of p21-driven cellular senescence. Oncogene |
| Xu Z, Wang Y, Xiao ZG, et al. (2018) Nuclear receptor ERRα and transcription factor ERG form a reciprocal loop in the regulation of TMPRSS2:ERG fusion gene in prostate cancer. Oncogene |
| Jia L, Wu D, Wang Y, et al. (2018) Orphan nuclear receptor TLX contributes to androgen insensitivity in castration-resistant prostate cancer via its repression of androgen receptor transcription. Oncogene |